1-(carboxymethylthio)tetradecane has been researched along with Leukemia, Myeloid, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berge, R; Erikstein, BS; Gjertsen, BT; McCormack, E; Schwede, F; Tronstad, KJ | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Drug Synergism; Enzyme Activators; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Peroxisome Proliferator-Activated Receptors; Rats; Sulfides | 2010 |